UCO Bank Q1 net profit up 10 pc to Rs 607 cr
The lender had posted a profit of Rs 551 crore in the year-ago period.
Kolkata, Jul 21 (PTI) State-run UCO Bank on Monday reported a 10.16 per cent year-on-year rise in net profit to Rs 607 crore for the April-June quarter of the 2025-26 financial year, driven by strong growth in advances and improved asset quality.
'Interest income from advances alone increased from around Rs 6,000 crore to Rs 6,400 crore year-on-year. Additionally, operating expenses increased by only 4 per cent, disproportionately lower than required, further contributing to profitability,' he said.
The guidance for net interest margin (NIM) has been revised downwards to a range of 2.9-3 per cent from the earlier projection of 3-3.10 per cent due to 'front-loading' loan repricing, he said.
The bank's operating profit for the June quarter in the current fiscal rose 18.24 per cent to Rs 1,562 crore, while net interest income (NII) increased by 6.61 per cent to Rs 2,403 crore during the period, the lender said in a statement.
The total business grew 13.51 per cent to Rs 5,23,736 crore as of June 30, 2025, supported by a 16.48 per cent jump in gross advances to Rs 2,25,101 crore.
Deposits rose 11.37 per cent to Rs 2,98,635 crore, the Kolkata-headquartered bank said.
Net Interest margin for the quarter stood at 2.96 per cent, it said.
The growth in the retail, agriculture, and MSME (RAM) segment remained strong, with advances in this category rising 23.47 per cent year-on-year to Rs 1,25,927 crore, the lender said.
Retail advances grew 30.73 per cent to Rs 56,195 crore, led by home and vehicle loans, which increased 17.92 per cent and 66.94 per cent, respectively.
The bank expects retail slippages to remain controlled and range-bound in the coming quarters, with no significant increase anticipated, the official said.
The domestic corporate advances stood at Rs 74,051 crore, a year-on-year growth of 14.61 per cent.
The bank intends to grow its corporate loan book in the range of 12-14 per cent in the upcoming quarters, Kumar said.
He stated that lending for startups is expected to gain traction with clarity on guarantee.
The asset quality saw an improvement with gross non-performing assets (NPA) declining to 2.63 per cent from 3.32 per cent a year ago, while net NPA fell to 0.45 per cent from 0.78 per cent.
The provision coverage ratio stood at 96.88 per cent.
The bank's capital adequacy ratio stood at 18.39 per cent, with Tier-I capital at 16.36 per cent.
As of June 30, 2025, the lender operated 3,305 branches, including two overseas branches in Hong Kong and Singapore, and had 16,803 customer touchpoints comprising ATMs and business correspondents. PTI BSM BDC
This report is auto-generated from PTI news service. ThePrint holds no responsibility for its content.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Hindu
19 minutes ago
- The Hindu
Dr. Reddy's Q1 net inches up amid decline in generics sales to U.S.
Generic drugmaker Dr. Reddy's Laboratories' consolidated net profit for the June quarter increased marginally to ₹1,409.9 crore from Rs.1,392.4 crore year earlier as revenue from the all important U.S. market declined amid increased price erosion in certain key products. The net profit came on a more than 11% increase in total revenue from operations to ₹.8,572.1 crore (₹.7,696.1 crore), the results prepared as per Indian Accounting Standards (Ind AS) showed. Pricing pressure on cancer drug Lenalidomide is expected to intensify in the U.S. generics market, according to co-chairman and MD G.V. Prasad. He said this reaffirming the company's focus on strengthening the base business by delivery of our pipeline assets, improving overall productivity and business development.' On segment revenue, the company said global generics contributed ₹7,573.2 crore (₹.6,892.9 crore), while share of Pharmaceutical Services and Active Ingredients declined to ₹987.4 crore (₹1,047.2 crore). In a release, on the results prepared as per International Financial Reporting Standards (IFRS), Dr. Reddy's said revenue from the North America generics market at ₹3,410 crore was 11% lower a decline YoY of and 4% QoQ. The decline was primarily due to increased price erosion in certain key products, including Lenalidomide. Revenue from generics sales in Europe, India and Emerging Markets were higher year on year. The company's shares closed less than 1% higher at ₹1,247.55 each on the BSE.
Time of India
19 minutes ago
- Time of India
Explained: Planning a trip to the US? Get ready to pay more than double visa fees
Explained: Planning a trip to the US? Get ready to pay more than double visa fees Team TOI Plus Jul 23, 2025, 18:37 IST IST Your visit to the US is about to get costlier with the Trump administration set to introduce a new 'visa integrity fee' in addition to the existing fee for all non-immigrant visas. Here's what you need to know and how much it will cost you Planning to visit the United States? It's likely to cost you an extra $250 or approximately Rs 22,000 - for Indians, that means paying more than double the existing visa fee.
Hans India
19 minutes ago
- Hans India
Aditya Birla Real Estate clocks Rs 27 crore loss in Q1, income falls over 55 pc
Mumbai: Aditya Birla Real Estate Limited (ABREL) on Wednesday reported a net loss of Rs 27.08 crore for the first quarter of the current financial year ( Q1 FY26). This marks a sharp reversal from the Rs 17.35 crore profit the company had recorded during the same period previous fiscal, according to its regulatory filing. The company's total income fell 56.9 per cent to Rs 157.41 crore in Q1 FY26, down from Rs 365.24 crore in the April–June quarter of FY25. During the quarter, ABREL reported a loss of Rs 47.30 crore from continued operations, while it registered a profit of Rs 20.22 crore from discontinued operations. The company recently exited its pulp and paper business, previously operated under the Century Pulp and Paper division, as part of its ongoing business restructuring. ABREL, formerly known as Century Textiles and Industries Limited, has also announced plans to raise up to Rs 1,500 crore through secured or unsecured rupee term loans. The fundraising is aimed at refinancing existing debts linked to capital expenditure for its now-sold pulp and paper division. The company said the move will help in releasing charges or encumbrances on the assets of that division, which is being sold to ITC. On the stock market front, Aditya Birla Real Estate shares have seen a 16 per cent decline in the past one month and are down 20 per cent year-to-date (YTD). The stock has fallen 24.85 per cent over the past year. However, over a longer period, the company has delivered strong returns -- rising 150 per cent in the last three years and delivering multi-bagger gains of 560 per cent over five years. At the closing bell, the company's shares were at Rs 2,019, down 5.51 per cent or Rs 117.8 on the National Stock Exchange (NSE) following the announcement of its Q1 results.
